PFIZER INC — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-11-30

Reporting Person: BOURLA ALBERT (Director, Chairman & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-30	Phantom Stock Units SSP	$	A	13.0000	Acquired		Common Stock (13.0000)	Direct

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F3: The unit/share positions in the Pfizer Stock Funds were increased upon the closing of the transactions (the "Transactions") contemplated in the Separation and Distribution Agreement and the Business Combination Agreement between the Company, Upjohn Inc., Mylan N.V. and certain of their affiliates, both entered into on July 29, 2019, to preserve the pre-Transaction market value of the Pfizer Stock Funds through the expected reduction in the share price of Pfizer common stock from the Transactions.